Crescent Capital BDC, Inc. (CCAP) Stock Forecast
CCAP analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.43 / 5 from 7 analysts
- Price target
- $12.25 average of analyst targets
- Upside to target
- +37.6% from the latest close
- Next earnings
- November 11, 2026 EPS estimate $0.35
- 52-week range
- $8.90 – $15.02
CCAP analyst ratings
7 analystsNumber of analysts at each rating.
CCAP price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CCAP earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.35 | $0.34 | $0.37 | $0.46 | −23.6% | 7 |
| Current fiscal year (2026) | $1.48 | $1.46 | $1.54 | $1.81 | −18.1% | 7 |
| Next fiscal year (2027) | $1.40 | $1.33 | $1.56 | $1.48 | −5.6% | 7 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CCAP revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $36.4M | $35.4M | $38.7M | −12.0% | 6 |
| Current fiscal year (2026) | $147.0M | $144.8M | $151.7M | −12.2% | 6 |
| Next fiscal year (2027) | $142.7M | $137.5M | $153.3M | −2.9% | 6 |
CCAP EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CCAP revenue: reported and forecast
CCAP EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.38 | $0.38 | $0.38 | $0.35 | $0.35 | −6.7% | 1 up · 5 down |
| Current fiscal year (2026) | $1.55 | $1.55 | $1.55 | $1.48 | $1.48 | −4.2% | 1 up · 5 down |
| Next fiscal year (2027) | $1.49 | $1.49 | $1.50 | $1.42 | $1.40 | −6.1% | 1 up · 6 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CCAP earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CCAP beat in 7 of 12.
What analysts expect from CCAP
7 analysts cover Crescent Capital BDC; their consensus rating is hold (3.43 on a 1–5 scale, where 5 is a strong buy). The average price target is $12.25, 37.6% above the latest close of $8.90. Analysts expect earnings of $1.48 per share for 2026, −18.1% from a year earlier. For 2027 the average estimate is $1.40 per share on revenue of $142.7 million. Crescent Capital BDC beat the EPS estimate in 7 of the last 12 quarters.
Related: CCAP income statement, CCAP key metrics, CCAP chart. See the CCAP stock overview for the latest quote and news.
CCAP forecast FAQ
What is Crescent Capital BDC's price target?
The average analyst price target for Crescent Capital BDC is $12.25, 37.6% above the latest close of $8.90.
Is Crescent Capital BDC a buy, hold or sell?
Of 7 analysts covering Crescent Capital BDC, 1 rate it a strong buy, 1 a buy, 5 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Crescent Capital BDC's EPS forecast?
Analysts forecast $1.48 per share for 2026 (range $1.46 to $1.54); for 2027 the estimate is $1.40.
What is Crescent Capital BDC's revenue forecast?
The average revenue estimate for 2026 is $147.0 million, growth of −12.2%; for 2027 it is $142.7 million.
When does Crescent Capital BDC report earnings?
Crescent Capital BDC is expected to report results for the quarter ending September 30, 2026 on November 11, 2026 after the market closes; the EPS estimate is $0.35.
Does Crescent Capital BDC usually beat earnings estimates?
Crescent Capital BDC reported EPS at or above the analyst estimate in 7 of the last 12 quarters.